Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by nemo3


V.TLT

Isaraeli cancer cure company vs TLT

A few days ago there was a lot of hype of an Israeli company that said they...

January 31, 2019

V.TLT

RE:I'm using CAD for my pricing

I wonder if charts can really be of much use on this stock. We need news and...

January 22, 2019

V.TLT

RE:RE:RE:Phase 2 trial

One thing that comes to mind too is how long it will take to get FDA approval...

January 22, 2019

V.TLT

RE:RE:Phase 2 trial

Wish u could edit posts. ITA is approved already. 

January 22, 2019

V.TLT

RE:Phase 2 trial

And of course REB and ITA

January 22, 2019

V.TLT

Phase 2 trial

https://health-products.canada.ca/ctdb-bdec/info.do This isn't new but...

January 22, 2019

V.TLT

RE:RE:OK, so I just spoke to Dr. Mandel

Thanks for the info BlueMetal. We just must be patient as hard as it is. ...

January 8, 2019

V.TLT

RE:RE:RE:AbbVie to Record $4 Billion Impairment on Stemcentrx Assets

very good point. Well explained Quattro. And that's a great point you...

January 5, 2019

V.TLT

RE:RE:RE:RE:RE:AbbVie to Record $4 Billion Impairment on Stemcentrx Assets

But testing on animals and testing on humans often has different results...

January 5, 2019

V.TLT

RE:RE:RE:AbbVie to Record $4 Billion Impairment on Stemcentrx Assets

I don't disagree with you chry in that TLT has shown some fantastic...

January 5, 2019

V.TLT

RE:AbbVie to Record $4 Billion Impairment on Stemcentrx Assets

Huge loss for the company. But just goes to show you why a company like TLT...

January 5, 2019

V.TLT

RE:RE:RE:RE:RE:Vicinium results out Prelim 12 months PH3

Interesting results. Of course,for TLT the wild card will be if the...

January 3, 2019

V.TLT

RE:TLT medical advisor being sued for improper practice

I don't think this will have any bearing on TLT. Dr Andrews is a medical...

November 6, 2018

V.TLT

RE:RE:Clinical Phases

Yes, that would be fantastic.... I would then be building a nice heated...

October 25, 2018

V.TLT

Clinical Phases

I think that many investors feel that at this stage TLT is far too early to...

October 25, 2018

V.TLT

RE:RE:RE:I tell people about this stock curing cancer no side effects

Yes, if the numbers are good then I do expect to make a handsome profit. ...

October 24, 2018

V.TLT

RE:I tell people about this stock curing cancer no side effects

Yeah, it would be nice to see a sustained higher price. But I guess at the...

October 24, 2018

V.TLT

Next phase of trial for bladder

 Will be interesting to see the treatment efficacy as more patients are...

June 30, 2018

V.TLT

Holding for the future

I will likely use the weakness to pick up a few more shares. I am like...

May 18, 2018

V.KDK

RE:RE:RE:RE:$ 67 for Dunedin too ?

DVI has more than 3x the outstanding shares that DiaMet had. Prior to the...

March 5, 2018

Featured Company